BioMotiv accelerates breakthrough discoveries into medicines through a unique business platform that brings pharmaceutical expertise, aligned capital, and industry partners together to support inventors and portfolio companies.
What We Do
Launch companies based on promising breakthrough discoveries from leading scientists and institutions.
Advance our companies' technologies to clinical studies.
Partner our portfolio companies for continued development and commercialization.
See Our Portfolio
What We Provide
BioMotiv provides the lead investment and actively secures additional funds to advance our portfolio companies.
We have established strategic partnerships with Takeda, Biogen, Arix Bioscience, and Charles River Laboratories to support technology development and commercialization.
Read more about Our Strategic Partnerships
Broad Business Networks
We have deep relationships in the investment and pharmaceutical industries that are accessed for the benefit of BioMotiv portfolio companies.
Efficient Operating Platform
BioMotiv provides an operating platform including business development, legal, financial, and administrative support to enable companies to focus their resources on their programs.